Imatinib-dependent tyrosine phosphorylation profiling of Bcr-Abl-positive chronic myeloid leukemia cells

Files in This Item:
File Description SizeFormat 
Paper61.pdf905.63 kBAdobe PDFDownload
Title: Imatinib-dependent tyrosine phosphorylation profiling of Bcr-Abl-positive chronic myeloid leukemia cells
Authors: Preisinger, C.
Schwarz, J. P.
Bleijerveld, O. B.
et al.
Permanent link:
Date: 27-Aug-2012
Abstract: Bcr-Abl is the major cause and pathogenetic principle of chronic myeloid leukemia (CML). Bcr-Abl results from a chromosomal translocation that fuses the bcr and abl genes, thereby generating a constitutively active tyrosine kinase, which stimulates several signaling networks required for proliferation and survival.
Type of material: Journal Article
Publisher: Nature Publishing Group
Journal: Leukemia
Volume: 27
Issue: 3
Start page: 743
End page: 746
Copyright (published version): 2012 Nature Publishing Group
Keywords: Bcr-Ablchronic myeloid leukemia (CML)
DOI: 10.1038/leu.2012.243
Language: en
Status of Item: Peer reviewed 2013-11-29T10:20:36Z
Appears in Collections:SBI Research Collection

Show full item record

Citations 20

Last Week
Last month
checked on Dec 12, 2018

Page view(s) 50

checked on May 25, 2018

Download(s) 50

checked on May 25, 2018

Google ScholarTM



This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. For other possible restrictions on use please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.